TY  - GEN
AU  - Strong,Randy
AU  - Miller,Richard A
AU  - Antebi,Adam
AU  - Astle,Clinton M
AU  - Bogue,Molly
AU  - Denzel,Martin S
AU  - Fernandez,Elizabeth
AU  - Flurkey,Kevin
AU  - Hamilton,Karyn L
AU  - Lamming,Dudley W
AU  - Javors,Martin A
AU  - de Magalhães,João Pedro
AU  - Martinez,Paul Anthony
AU  - McCord,Joe M
AU  - Miller,Benjamin F
AU  - Müller,Michael
AU  - Nelson,James F
AU  - Ndukum,Juliet
AU  - Rainger,G Ed
AU  - Richardson,Arlan
AU  - Sabatini,David M
AU  - Salmon,Adam B
AU  - Simpkins,James W
AU  - Steegenga,Wilma T
AU  - Nadon,Nancy L
AU  - Harrison,David E
TI  - Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer
SN  - 1474-9726
PY  - 2017///0605
KW  - Acarbose
KW  - pharmacology
KW  - Animals
KW  - Antioxidants
KW  - Drugs, Chinese Herbal
KW  - Estradiol
KW  - Fish Oils
KW  - Glycoside Hydrolase Inhibitors
KW  - Hand Strength
KW  - Longevity
KW  - drug effects
KW  - Male
KW  - Masoprocol
KW  - Metformin
KW  - Mice
KW  - NF-E2-Related Factor 2
KW  - metabolism
KW  - Rotarod Performance Test
KW  - Sirolimus
KW  - Survival Analysis
KW  - Ursodeoxycholic Acid
KW  - alpha-Glucosidases
N1  - Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1111/acel.12496
ER  -